叶瑞绒 - 昆明理工大学 - 生命科学与技术学院

个人简介

教育经历 (1) 2010.9–2015.7，中山大学，化学，博士，导师：毛宗万 (2) 2006.9–2010.7，四川大学，化学，学士，导师：胡常伟科研与学术工作经历 (1) 2017.8-至今，昆明理工大学，生命科学与技术学院，副教授 (2) 2015.8-2017.8，中山大学，博士后，合作导师：陈小明，毛宗万

研究领域

从事的学科领域为生物无机化学。主要为靶向性金属抗肿瘤药物的设计、抗肿瘤活性及机制研究，抗肿瘤靶点涉及组蛋白去乙酰化酶（HDACs）、线粒体、溶酶体等。

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

(1) Ye Ruirong; Cao Jianjun; Tan Caiping; Ji Liangnian; Mao Zongwan*, Valproic acid-functionalized cyclometalated iridium(III) complexes as mitochondria-targeting anticancer agents, Chemistry-A European Journal, 2017.10.26, 23(60): 15166~15176. （2) Ye Ruirong; Tan Caiping*; Ji Liangnian; Mao Zongwan*, Coumarin-appended phosphorescent cyclometalated iridium(III) complexes as mitochondria-targeted theranostic anticancer agents, Dalton Transactions, 2016.9.7, 45(33): 13042~13051. （3) Ye Ruirong; Tan Caiping*; Chen Muhe; Hao Liang; Ji Liangnian; Mao Zongwan*, Mono- and dinuclear phosphorescent rhenium(I) complexes: impact of subcellular localization on anticancer mechanisms, Chemistry-A European Journal, 2016.4.23, 22(23): 7800~7809. （4) Ye Ruirong; Tan Caiping*; Lin Yannan; Ji Liangnian; Mao Zongwan*, A phosphorescent rhenium(I) histone deacetylases inhibitor: mitochondrial targeting and paraptosis induction, Chemical Communications, 2015.4.13, 51(39): 8353~8356. （5) Ye Ruirong; Tan Caiping*; He Liang; Chen Muhe; Ji Liangnian; Mao Zongwan*, Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy, Chemical Communications, 2014.7.29, 50(75): 10945~10948. （6) Ye Ruirong; Ke Zhuofeng; Tan Caiping*; He Liang; Ji Liangnian; Mao Zongwan*, Histone-deacetylase-targeted fluorescent ruthenium(II) polypyridyl complexes as potent anticancer agents, Chemistry-A European Journal, 2013.7.4, 19(31): 10160~10169. （7) 叶瑞绒; 谭彩萍*; 计亮年; 毛宗万*, 磷光过渡金属配合物用于生物成像及癌症治疗的研究进展, 药学进展, 2017.1.4, 41(1): 4~16.